Lilly,Sanofi Enter Into Settlement Agreement In US Insulin Glargine Litigation
Permalink

Lilly,Sanofi Enter Into Settlement Agreement In US Insulin Glargine Litigation

Separately, Sanofi confirmed that it has reached a settlement agreement with Eli Lilly and Company,…

Continue Reading →

Sanofi lands EC approval for its cholesterol-busting Praluent
Permalink

Sanofi lands EC approval for its cholesterol-busting Praluent

Investors in healthcare giants Regeneron Pharmaceuticals (NASDAQ:REGN) and Sanofi (NYSE:SNY) were given another reason to…

Continue Reading →

Advertisement

Sanofi: Combination Diabetes Drug Reaches Target in Second Phase 3 Trial
Permalink

Sanofi: Combination Diabetes Drug Reaches Target in Second Phase 3 Trial

The LisiLan-L Phase III clinical trial has now met its primary endpoints in patients affected…

Continue Reading →

Sanofi, Evotec, Apeiron make cancer-therapy deal
Permalink

Sanofi, Evotec, Apeiron make cancer-therapy deal

Evotec AG and Apeiron Biologics AG has recently entered a new strategic collaboration with French…

Continue Reading →